Insider Trading activities at Labcorp Holdings Inc. (LH) , Part 3

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Labcorp Holdings Inc. (LH) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Labcorp Holdings Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 920148.

Total stock buying since 2015: $1,043,003.
Total stock sales since 2015: $227,188,909.
Total stock option exercises since 2015: $77,979,648.

1 2 3 4

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at *Labcorp Holdings Inc.* (LH).
	Insider Buying		Insider Sales		Option Exercises
Year	Shares	Value	Shares	Value	Shares	Value
2026	0	$0	5,539	$1,574,234	31,825	$0
2025	0	$0	66,142	$17,019,293	45,398	$1,257,151
2024	0	$0	114,101	$25,564,557	223,629	$5,747,628
2023	0	$0	25,727	$5,898,171	36,612	$1,528,223
2022	3,586	$943,644	67,587	$16,222,919	61,209	$4,828,658
2021	0	$0	19,104	$5,173,650	58,665	$1,504,266
2020	580	$99,359	64,377	$11,277,851	57,175	$367,326
2019	0	$0	75,574	$12,575,709	66,943	$1,208,386
2018	0	$0	202,786	$34,698,881	227,331	$14,311,624
2017	0	$0	241,007	$37,606,912	281,483	$19,203,709
2016	0	$0	250,840	$31,873,214	253,801	$13,931,362
2015	0	$0	225,659	$27,703,518	244,859	$14,091,315

Table 3. Detailed insider trading at *Labcorp Holdings Inc.* (LH) , Part 3
Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2022-02-02	Davis Jeffrey A. (Director)	Option Ex	771	.00	0
2022-02-02	Gilliland Dwight Gary (Director)	Option Ex	771	.00	0
2022-02-02	Parham Richelle P (Director)	Option Ex	771	.00	0
2022-02-02	Van Der Vaart Sandra D (EVP, Chief Legal Officer)	Option Ex	236	.00	0
2022-02-02	Kong Garheng (Director)	Option Ex	771	.00	0
2022-02-02	Wilkinson Peter J (SVP, Chief Accounting Officer)	Option Ex	116	.00	0
2022-02-02	Schechter Adam H (President & CEO)	Option Ex	2,773	.00	0
2022-02-02	Williams R Sanders (Director)	Option Ex	771	.00	0
2022-02-02	Neupert Peter M (Director)	Option Ex	771	.00	0
2022-02-02	Anderson Kerrii B (Director)	Option Ex	771	.00	0
2022-02-02	Eisenberg Glenn A (Chief Financial Officer, EVP)	Option Ex	766	.00	0
2022-02-02	Belingard Jean-luc (Director)	Option Ex	771	.00	0
2022-02-02	Berberian Lance (EVP, CIO & CTO)	Option Ex	296	.00	0
2021-12-15	Gilliland Dwight Gary (Director)	Sale	500	302.27	151,137
2021-11-05	Schroeder Mark S (EVP, President-Diagnostics Lab)	Option Ex	2,010	.00	0
2021-11-05	Caveney Brian J (EVP, President of Diagnostics)	Option Ex	2,010	.00	0
2021-11-01	Kirchgraber Paul R (CEO, Covance Drug Development)	Option Ex	2,007	.00	0
2021-11-01	Schechter Adam H (President & CEO)	Option Ex	2,007	.00	0
2021-11-01	Eisenberg Glenn A (Chief Financial Officer, EVP)	Option Ex	9,024	.00	0
2021-09-15	Van Der Vaart Sandra D (EVP, Chief Legal Officer)	Sale	4,500	296.78	1,335,509
2021-09-15	Van Der Vaart Sandra D (EVP, Chief Legal Officer)	Option Ex	4,500	84.86	381,870
2021-08-01	Wilkinson Peter J (SVP, Chief Accounting Officer)	Option Ex	50	.00	0
2021-06-07	Van Der Vaart Sandra D (EVP, Chief Legal Officer)	Sale	4,500	266.56	1,199,520
2021-06-07	Van Der Vaart Sandra D (EVP, Chief Legal Officer)	Option Ex	4,500	84.86	381,870
2021-05-06	Kirchgraber Paul R (CEO, Covance Drug Development)	Sale	2,500	276.55	691,375
2021-05-03	Belingard Jean-luc (Director)	Sale	2,600	269.15	699,802
2021-05-03	Belingard Jean-luc (Director)	Option Ex	2,600	98.49	256,074
2021-04-03	Kirchgraber Paul R (CEO, Covance Drug Development)	Option Ex	1,010	.00	0
2021-03-30	Schroeder Mark S (EVP, President-Diagnostics Lab)	Sale	667	251.88	168,003
2021-03-30	Van Der Vaart Sandra D (EVP, Chief Legal Officer)	Sale	812	251.88	204,526
2021-02-18	Wilkinson Peter J (SVP, Chief Accounting Officer)	Sale	2,317	241.51	559,590
2021-02-18	Wilkinson Peter J (SVP, Chief Accounting Officer)	Option Ex	2,166	164.55	356,415
2021-02-16	Schroeder Mark S (EVP, President-Diagnostics Lab)	Sale	188	237.06	44,567
2021-02-16	Van Der Vaart Sandra D (EVP, Chief Legal Officer)	Sale	208	236.33	49,157
2021-02-12	Schroeder Mark S (EVP, President-Diagnostics Lab)	Option Ex	517	.00	0
2021-02-12	Kirchgraber Paul R (CEO, Covance Drug Development)	Option Ex	581	.00	0
2021-02-12	Caveney Brian J (EVP, President of Diagnostics)	Option Ex	2,870	.00	0
2021-02-12	Van Der Vaart Sandra D (EVP, Chief Legal Officer)	Option Ex	573	.00	0
2021-02-12	Wilkinson Peter J (SVP, Chief Accounting Officer)	Option Ex	867	.00	0
2021-02-12	Eisenberg Glenn A (Chief Financial Officer, EVP)	Option Ex	1,720	.00	0
2021-02-12	Berberian Lance (EVP, CIO & CTO)	Option Ex	2,940	.00	0
2021-02-05	Schroeder Mark S (EVP, President-Diagnostics Lab)	Sale	203	225.85	45,847
2021-02-05	Van Der Vaart Sandra D (EVP, Chief Legal Officer)	Sale	109	225.85	24,617
2021-02-04	Summy Amy B. (EVP, Chief Marketing Officer)	Option Ex	266	.00	0
2021-02-04	Schroeder Mark S (EVP, President-Diagnostics Lab)	Option Ex	560	.00	0
2021-02-04	Kirchgraber Paul R (CEO, Covance Drug Development)	Option Ex	560	.00	0
2021-02-04	Seltz Judith C (EVP, CHRO)	Option Ex	280	.00	0
2021-02-04	Caveney Brian J (EVP, President of Diagnostics)	Option Ex	560	.00	0
2021-02-04	Davis Jeffrey A. (Director)	Option Ex	986	.00	0
2021-02-04	Gilliland Dwight Gary (Director)	Option Ex	986	.00	0
2021-02-04	Parham Richelle P (Director)	Option Ex	986	.00	0
2021-02-04	Van Der Vaart Sandra D (EVP, Chief Legal Officer)	Option Ex	300	.00	0
2021-02-04	Kong Garheng (Director)	Option Ex	986	.00	0
2021-02-04	Wilkinson Peter J (SVP, Chief Accounting Officer)	Option Ex	150	.00	0
2021-02-04	Schechter Adam H (President & CEO)	Option Ex	3,506	.00	0
2021-02-04	Williams R Sanders (Director)	Option Ex	986	.00	0
2021-02-04	Neupert Peter M (Director)	Option Ex	986	.00	0
2021-02-04	Anderson Kerrii B (Director)	Option Ex	986	.00	0
2021-02-04	Eisenberg Glenn A (Chief Financial Officer, EVP)	Option Ex	970	.00	0
2021-02-04	Belingard Jean-luc (Director)	Option Ex	986	.00	0
2021-02-04	Berberian Lance (EVP, CIO & CTO)	Option Ex	373	.00	0
2021-01-26	Williams R Sanders (Director)	Option Ex	1,300	98.49	128,037
2020-12-01	Davis Jeffrey A. (Director)	Option Ex	173	.00	0
2020-11-06	Schroeder Mark S (EVP, President-Diagnostics Lab)	Sale	588	214.59	126,178
2020-11-05	Schroeder Mark S (EVP, President-Diagnostics Lab)	Option Ex	2,010	.00	0
2020-11-05	Caveney Brian J (EVP, President of Diagnostics)	Option Ex	2,010	.00	0
2020-11-04	Kirchgraber Paul R (CEO, Covance Drug Development)	Sale	1,500	214.14	321,204
2020-11-02	Kirchgraber Paul R (CEO, Covance Drug Development)	Option Ex	2,006	.00	0
2020-11-02	Schechter Adam H (President & CEO)	Option Ex	2,006	.00	0
2020-11-02	Eisenberg Glenn A (Chief Financial Officer, EVP)	Option Ex	9,024	.00	0
2020-09-25	Caveney Brian J (EVP, President of Diagnostics)	Option Ex	970	.00	0
2020-07-08	Williams R Sanders (Director)	Sale	1,300	173.12	225,056
2020-07-08	Williams R Sanders (Director)	Option Ex	1,300	98.49	128,037
2020-07-02	Van Der Vaart Sandra D (EVP, Chief Legal Officer)	Sale	435	170.00	73,950
2020-06-24	Van Der Vaart Sandra D (EVP, Chief Legal Officer)	Sale	872	160.33	139,807
2020-05-05	King David P (Director)	Sale	31,250	160.00	5,000,000
2020-04-03	Kirchgraber Paul R (CEO, Covance Drug Development)	Option Ex	1,010	.00	0
2020-03-10	Seltz Judith C (EVP, CHRO)	Buy	330	168.56	55,624
2020-02-28	Seltz Judith C (EVP, CHRO)	Buy	250	174.94	43,735
2020-02-21	Wilkinson Peter J (SVP, Chief Accounting Officer)	Sale	297	189.65	56,325
2020-02-19	Belingard Jean-luc (Director)	Sale	26,479	189.76	5,024,760
2020-02-19	Belingard Jean-luc (Director)	Option Ex	3,100	77.19	239,289
2020-02-13	Schroeder Mark S (EVP, President-Diagnostics Lab)	Sale	188	188.49	35,436
2020-02-13	Williams R Sanders (Director)	Sale	1,227	188.49	231,277
2020-02-12	Schroeder Mark S (EVP, President-Diagnostics Lab)	Option Ex	516	.00	0
2020-02-12	Kirchgraber Paul R (CEO, Covance Drug Development)	Option Ex	579	.00	0
2020-02-12	Caveney Brian J (EVP, President of Diagnostics)	Option Ex	2,869	.00	0
2020-02-12	Gilliland Dwight Gary (Director)	Option Ex	1,227	.00	0
2020-02-12	Parham Richelle P (Director)	Option Ex	1,227	.00	0
2020-02-12	Kong Garheng (Director)	Option Ex	1,227	.00	0
2020-02-12	Wilkinson Peter J (SVP, Chief Accounting Officer)	Option Ex	866	.00	0
2020-02-12	Schechter Adam H (President & CEO)	Option Ex	1,227	.00	0
2020-02-12	Williams R Sanders (Director)	Option Ex	1,227	.00	0
2020-02-12	King David P (Director)	Option Ex	7,749	.00	0
2020-02-12	Neupert Peter M (Director)	Option Ex	1,227	.00	0
2020-02-12	Anderson Kerrii B (Director)	Option Ex	1,227	.00	0
2020-02-12	Eisenberg Glenn A (Chief Financial Officer, EVP)	Option Ex	1,720	.00	0
2020-02-12	Belingard Jean-luc (Director)	Option Ex	1,227	.00	0
2020-02-12	Berberian Lance (SVP, Chief Information Officer)	Option Ex	2,939	.00	0
2020-02-10	Schroeder Mark S (EVP, President-Diagnostics Lab)	Sale	108	181.99	19,654
2020-02-10	Van Der Vaart Sandra D (SVP, Global General Counsel)	Sale	133	181.99	24,204
2020-02-07	Schroeder Mark S (EVP, President-Diagnostics Lab)	Option Ex	297	.00	0
2020-02-07	Kirchgraber Paul R (CEO, Covance Drug Development)	Option Ex	337	.00	0
2020-02-07	Van Der Vaart Sandra D (SVP, Global General Counsel)	Option Ex	367	.00	0
2020-02-07	King David P (Director)	Option Ex	4,220	.00	0
2020-02-07	Eisenberg Glenn A (Chief Financial Officer, EVP)	Option Ex	994	.00	0
2020-02-07	Berberian Lance (SVP, Chief Information Officer)	Option Ex	297	.00	0
2019-12-04	Belingard Jean-luc (Director)	Option Ex	3,271	.00	0
2019-10-28	King David P (President & CEO)	Sale	30,177	165.23	4,986,115
2019-09-23	Anderson Kerrii B (Director)	Sale	2,600	171.85	446,810
2019-09-23	Anderson Kerrii B (Director)	Option Ex	2,600	98.49	256,074
2019-09-04	Uthgenannt Lisa J (Chief Human Resources Officer)	Sale	2,466	168.59	415,742
2019-09-04	Uthgenannt Lisa J (Chief Human Resources Officer)	Option Ex	2,466	130.60	322,059
2019-08-30	Berberian Lance (SVP, Chief Information Officer)	Sale	5,902	169.80	1,002,171
2019-08-05	Williams R Sanders (Director)	Sale	500	162.91	81,455
2019-07-08	Van Der Vaart Sandra D (SVP, Global General Counsel)	Sale	2,328	176.75	411,474
2019-07-08	Eisenberg Glenn A (Chief Financial Officer, EVP)	Sale	5,563	176.75	983,260
2019-06-20	Anderson Kerrii B (Director)	Sale	3,100	170.00	527,000
2019-06-20	Anderson Kerrii B (Director)	Option Ex	3,100	77.19	239,289
2019-06-07	Eisenberg Glenn A (Chief Financial Officer, EVP)	Sale	10,000	167.63	1,676,279
2019-05-09	Mittelstaedt Robert E Jr (Director)	Option Ex	306	.00	0
2019-05-06	Williams R Sanders (Director)	Sale	500	162.20	81,100
2019-05-03	Mittelstaedt Robert E Jr (Director)	Sale	3,700	166.30	615,310
2019-05-03	Mittelstaedt Robert E Jr (Director)	Option Ex	3,700	64.42	238,354
2019-05-02	Uthgenannt Lisa J (Chief Human Resources Officer)	Sale	4,000	164.00	656,000
2019-04-03	Ratliff John D (CEO, Covance Drug Development)	Option Ex	2,424	.00	0
2019-02-13	Williams R Sanders (Director)	Sale	1,038	147.00	152,586
2019-02-12	Caveney Brian J (SVP, Chief Medical Officer)	Option Ex	233	.00	0
2019-02-12	Uthgenannt Lisa J (Chief Human Resources Officer)	Option Ex	256	.00	0
2019-02-12	Dodson Edward T (Principal Accounting Officer)	Option Ex	196	.00	0
2019-02-12	Gilliland Dwight Gary (Director)	Option Ex	1,038	.00	0
2019-02-12	Parham Richelle P (Director)	Option Ex	1,038	.00	0
2019-02-12	Kong Garheng (Director)	Option Ex	1,038	.00	0
2019-02-12	Schechter Adam H (Director)	Option Ex	1,038	.00	0
2019-02-12	Williams R Sanders (Director)	Option Ex	1,038	.00	0
2019-02-12	King David P (President & CEO)	Option Ex	3,513	.00	0
2019-02-12	Neupert Peter M (Director)	Option Ex	1,038	.00	0
2019-02-12	Anderson Kerrii B (Director)	Option Ex	1,038	.00	0
2019-02-12	Mittelstaedt Robert E Jr (Director)	Option Ex	1,038	.00	0
2019-02-12	Belingard Jean-luc (Director)	Sale	3,700	146.06	540,407
2019-02-12	Belingard Jean-luc (Director)	Option Ex	4,738	32.21	152,610
2019-02-11	Uthgenannt Lisa J (Chief Human Resources Officer)	Option Ex	604	.00	0
2019-02-11	Dodson Edward T (Principal Accounting Officer)	Option Ex	450	.00	0
2019-02-11	Ratliff John D (CEO, Covance Drug Development)	Option Ex	6,100	.00	0
2019-02-11	King David P (President & CEO)	Option Ex	7,544	.00	0
2019-02-11	Eberts F Samuel Iii (Chief Legal Officer, Secretary)	Option Ex	520	.00	0
2019-02-11	Eisenberg Glenn A (Chief Financial Officer, EVP)	Option Ex	4,877	.00	0
2019-02-11	Berberian Lance (SVP, Chief Information Officer)	Option Ex	3,497	.00	0
2019-02-07	Uthgenannt Lisa J (Chief Human Resources Officer)	Option Ex	327	.00	0
2019-02-07	Dodson Edward T (Principal Accounting Officer)	Option Ex	247	.00	0

1 2 3 4

Insider trading activities including stock purchases, stock sales, and option exercises of LH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Labcorp Holdings Inc. (symbol LH, CIK number 920148) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month